Related references
Note: Only part of the references are listed.Pharmacological inactivation of the prion protein by targeting a folding intermediate
Giovanni Spagnolli et al.
COMMUNICATIONS BIOLOGY (2021)
Neuroinflammation in Prion Disease
Bei Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Strain diversity in neurodegenerative disease: an argument for a personalized medicine approach to diagnosis and treatment
Amanda L. Woerman
ACTA NEUROPATHOLOGICA (2021)
Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice
Tahir Ali et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Genetic prion disease-related mutation E196K displays a novel amyloid fibril structure revealed by cryo-EM
Li-Qiang Wang et al.
SCIENCE ADVANCES (2021)
Small Molecules with Anti-Prion Activity
Carlo Mustazza et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Discovery of a multipotent chaperone, 1-(2,6-Difluorobenzylamino)-3-(1,2,3,4-tetrahydrocarbazol-9-yl)-propan-2-ol with the inhibitory effects on the proliferation of prion, cancer as well as influenza virus
Satoshi Yamashita et al.
PRION (2020)
A Review on Applications of Computational Methods in Drug Screening and Design
Xiaoqian Lin et al.
MOLECULES (2020)
Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core
Calina Glynn et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Stilbene Compounds Inhibit the Replications of Various Strains of Prions in the Levels of Cell Culture, PMCA, and RT-QuIC Possibly via Molecular Binding
Dong-Hua Zhou et al.
ACS CHEMICAL NEUROSCIENCE (2020)
In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives
Ludovica Zaccagnini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel regulators of PrP©expression as potential therapeutic targets in prion diseases
Arianna Colini Baldeschi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Cryo-EM structure of an amyloid fibril formed by full-length human prion protein
Li-Qiang Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques
Keiichi Yamaguchi et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Clinical trials of prion disease therapeutics
Gianluigi Forloni et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Novel screening approaches for human prion diseases drug discovery
Fabio Moda et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease
Allyson Connor et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation
Lesley Uttley et al.
LANCET INFECTIOUS DISEASES (2019)
Identifying Anti-prion Chemical Compounds Using a Newly Established Yeast High-Throughput Screening System
Zhiqiang Du et al.
CELL CHEMICAL BIOLOGY (2019)
Toward Therapy of Human Prion Diseases
Adriano Aguzzi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Claudio Soto et al.
NATURE NEUROSCIENCE (2018)
A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds
Carol L. Ladner-Keay et al.
PRION (2018)
Solvation-Guided Design of Fluorescent Probes for Discrimination of Amyloids
Kevin J. Cao et al.
SCIENTIFIC REPORTS (2018)
The function of the cellular prion protein in health and disease
Joel C. Watts et al.
ACTA NEUROPATHOLOGICA (2018)
Pharmacological Agents Targeting the Cellular Prion Protein
Maria Letizia Barreca et al.
PATHOGENS (2018)
Identification of novel fluorescent probes preventing PrPSc replication in prion diseases
Ludovica Zaccagnini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Analysis of [SWI+] formation and propagation events
Zhiqiang Du et al.
MOLECULAR MICROBIOLOGY (2017)
Elucidating the function of the prion protein
Giuseppe Legname
PLOS PATHOGENS (2017)
Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach
Mattia Toni et al.
FRONTIERS IN NEUROSCIENCE (2017)
The biological function of the cellular prion protein: an update
Marie-Angela Wulf et al.
BMC BIOLOGY (2017)
Physiological Functions of the Cellular Prion Protein
Andrew R. Castle et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2017)
Identification of Anti-prion Compounds using a Novel Cellular Assay
Thibaut Imberdis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease?
Maria Laura Bolognesi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases
Thibaut Imberdis et al.
MOLECULAR NEURODEGENERATION (2016)
Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation
Daisuke Ishibashi et al.
EBIOMEDICINE (2016)
The Effects of Ca2+ Concentration and E200K Mutation on the Aggregation Propensity of PrPC : A Computational Study
Alessandro Marrone et al.
PLOS ONE (2016)
Imaging of beta-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience
Matteo Staderini et al.
CHEMICAL SOCIETY REVIEWS (2015)
Rational approach to an antiprion compound with a multiple mechanism of action
Maria Laura Bolognesi et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Investigation of the molecular similarity in closely related protein systems: The PrP case study
Loriano Storchi et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2015)
The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion
Gabriele Giachin et al.
SCIENTIFIC REPORTS (2015)
Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches
Jae Wook Hyeon et al.
SCIENTIFIC REPORTS (2015)
Structure-Activity Relationship Study around Guanabenz Identifies Two Derivatives Retaining Antiprion Activity but Having Lost α2-Adrenergic Receptor Agonistic Activity
Phu Hai Nguyen et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases
Salvatore Bongarzone et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases
Sina Ghaemmaghami et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
Stephane Haik et al.
LANCET NEUROLOGY (2014)
Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD
Michal Mizrahi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Strategic Focus on 3R Principles Reveals Major Reductions in the Use of Animals in Pharmaceutical Toxicity Testing
Elin Tornqvist et al.
PLOS ONE (2014)
Synthesis of an 11C-Labeled Antiprion GN8 Derivative and Evaluation of Its Brain Uptake by Positron Emission Tomography
Tsutomu Kimura et al.
CHEMMEDCHEM (2013)
Modulation of Prion by Small Molecules: From Monovalent to Bivalent and Multivalent Ligands
Matteo Staderini et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease
Leo H. Wang et al.
JOURNAL OF NEUROLOGY (2013)
Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents
Yervand Eduard Karapetyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer's and Prion Diseases
Matteo Staderini et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Discovery and Preliminary Structure-Activity Relationship of Arylpiperazines as Novel, Brain-Penetrant Antiprion Compounds
Zhe Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Towards Optimization of Arylamides As Novel, Potent, and Brain-Penetrant Antiprion Lead Compounds
Zhe Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
Veda Prachayasittikul et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
Rik Vandenberghe et al.
NEUROIMAGE-CLINICAL (2013)
Dye-Binding Assays for Evaluation of the Effects of Small Molecule Inhibitors on Amyloid (Aβ) Self-Assembly
Laramie P. Jameson et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases
Caries Galdeano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Aminonaphthalene 2-Cyanoacrylate (ANCA) Probes Fluorescently Discriminate between Amyloid-β and Prion Plaques in Brain
Kevin Cao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Hybrid Lipoic Acid Derivatives to Attack Prion Disease on Multiple Fronts
Salvatore Bongarzone et al.
CHEMMEDCHEM (2011)
From High-Throughput Cell Culture Screening to Mouse Model: Identification of New Inhibitor Classes against Prion Disease
Markus Geissen et al.
CHEMMEDCHEM (2011)
Oligomeric-Induced Activity by Thienyl Pyrimidine Compounds Traps Prion Infectivity
Adeline Ayrolles-Torro et al.
JOURNAL OF NEUROSCIENCE (2011)
Redox Control of Prion and Disease Pathogenesis
Neena Singh et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Discovery of a Class of Diketopiperazines as Antiprion Compounds
Maria Laura Bolognesi et al.
CHEMMEDCHEM (2010)
Parallel Synthesis, Evaluation, and Preliminary Structure-Activity Relationship of 2,5-Diamino-1,4-benzoquinones as a Novel Class of Bivalent Anti-Prion Compound
Salvatore Bongarzone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Theoretical Study of the Prion Protein Based on the Fragment Molecular Orbital Method
Takeshi Ishikawa et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Regulating the Conformation of Prion Protein through Ligand Binding
Norifumi Yamamoto et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process
M. Pera et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Prions: Protein Aggregation and Infectious Diseases
Adriano Aguzzi et al.
PHYSIOLOGICAL REVIEWS (2009)
Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease
Reinald Pamplona et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Antihypertensive Drug Guanabenz Is Active In Vivo against both Yeast and Mammalian Prions
Deborah Tribouillard-Tanvier et al.
PLOS ONE (2008)
Hot spots in prion protein for pathogenic conversion
Kazuo Kuwata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The cellular prion protein (PrPC): Its physiological function and role in disease
Laura Westergard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration
Maria L. Bolognesi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Oxidative stress in the brain at early preclinical stages of mouse scrapie
Seong-Wook Yun et al.
EXPERIMENTAL NEUROLOGY (2006)
Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments
Ralf Klingenstein et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Acetylcholinesterase triggers the aggregation of PrP 106-126
M. Pera et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease
B Van Everbroeck et al.
ACTA NEUROPATHOLOGICA (2004)
Combined quinacrine and chlorpromazine therapy in fatal familial insomnia
J Benito-León
CLINICAL NEUROPHARMACOLOGY (2004)
Diagnosis of prion diseases
E Kubler et al.
BRITISH MEDICAL BULLETIN (2003)
Locally disordered conformer of the hamster prion protein:: A crucial intermediate to PrPSc?
K Kuwata et al.
BIOCHEMISTRY (2002)
Tetracyclines affect prion infectivity
G Forloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The use of antioxidants in transmissible spongiform encephalopathies: A case report
JA Drisko
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2002)
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
C Korth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Shattuck lecture - Neurodegenerative diseases and prions.
SB Prusiner
NEW ENGLAND JOURNAL OF MEDICINE (2001)
NMR solution structure of the human prion protein
R Zahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
